Dr. Dawn-Elise Snipes is a Licensed Professional Counselor and Qualified Clinical Supervisor. She received her PhD in Mental Health Counseling from the University of Florida in 2002. In addition to being a practicing clinician, she has provided training to counselors, social workers, nurses and case managers internationally since 2006 through AllCEUs.com 📢SUBSCRIBE and click the BELL to get notified when new videos are uploaded. 💲 Unlimited CEUs $59 based on these videos at allceus.com for social work, counseling, marriage and family therapy, addiction counseling, case management, pastoral counseling and more. 👋 Chat with me at https://members.docsnipes.com/ For $10/month where you get access to my tips for health and wellness and you can text chat with me privately 7 days a week. #CBD#PTSDtreatment#EndAlz#cheapceus
CBD in the Treatment of PTSD, Alzheimers, Addiction and Mood Disorders Neuroprotective potential of CBD, based on the combination of its anti-inflammatory and anti-oxidant properties, presently under investigation in numerous neurodegenerative disorder including AD, PD and HD Previous clinical studies using CBD concentrated on symptom relief in HD rather than on disease progression and did not show any significant improvement
Regarding PD, activation of CB1 receptors (via THC) enhances rather motor disability; however, CBD acts independently of those receptors major efforts are being directed at finding cannabinoid molecules that provide neuroprotection through their anti-oxidant properties and activate CB2 but not CB1 receptors
Oral CBD in addition to routine psychiatric care was associated with PTSD symptom reduction in adults CBD also appeared to offer relief from frequent nightmares as a symptom of their PTSD.
CBD seems to blunt the rewarding properties of many drugs (including THC) Clinical trials currently focus on CBD for people addicted to opioids or cocaine Animal studies find that CBD reduces the overall level of alcohol intake,
I'd like to welcome everybody to this presentation on CBD or cannabidiol in the treatment of
PTSD, Alzheimer's, addiction, and mood disorders.
Cannabidiol for neurodegenerative disorders.
Let's just start there since we finished in the last presentation talking about neurodegenerative
disorders.
CBD or cannabidiol, and I'm going to call it CBD from here on out just because it's
It can be very neuroprotective based on its combination of anti-inflammatory, antioxidant
properties.
Now, remember that inflammation is one of our big bugaboos that contributes to problems
in our nervous system and problems in our immune system.
When we have inflammation, that is our immune system sending out inflammatory cytokines
throughout our body.
So our immune system's in overdrive and that can cause a whole bunch of other issues.
So anti-inflammatory is important.
We know inflammation is associated with NDs as well as mood disorders and even some other
psychiatric disorders.
Antioxidant, now, oxidative stress.
Most people have already put these together, but I will just string it together because
we've got the time.
Free radicals are caused by your system being in overdrive and or inflammation.
When you've got too many free radicals in your system, leftover byproducts from bodily
processes, your body can't clear it out enough.
It creates inflammation and they call that oxidative stress.
Antioxidants are actually things that assist the body in removing those free radicals.
They're removing that oxidative stress.
So CBD actually has the ability to remove some of that oxidative stress.
CBD is presently under investigation in numerous neurodegenerative disorder conditions, including
Alzheimer's, Parkinson's disease, and Huntington's disease.
Previous clinical studies using CBD concentrated on symptom relief only in Huntington's disease
and it looked at symptom relief instead of disease progression.
Well, in terms of symptom relief, CBD did not seem to show much benefit for people with
Huntington's disease.
However, they believe that it may have been somewhat effective in slowing disease progression
by reducing some of the inflammation in the system.
Now, a lot of that is anecdotal at this point.
Regarding Parkinson's disease, activation of CB1 receptors, which is the cannabinoid
receptor that's activated by THC, enhances motor disability instead of improving it.
So THC, which is the psychoactive component of cannabis, actually has been shown to make
a lot of Parkinson's symptoms worse.
So we want to note that.
But CBD, interestingly enough, acts independently of the cannabinoid receptors.
Even though it's a cannabinoid, it actually acts independently.
It doesn't actually target the receptors.
It prevents the breakdown of endogenous opioid, I'm sorry, I always do that, endogenous cannabinoids
like anandamide.
So CBD actually doesn't target the receptors as much directly.
It targets them indirectly.
And I made this hand gesture because a lot of times we talk about targeting receptors
as turning a key in a lock.
So I just have that automatic hand movement, if you're wondering what I was doing.
Anyhow, major efforts are being directed at finding cannabinoid molecules that provide
neuroprotection through their antioxidant properties and activate CB2, but not CB1 receptors.
And you may be going, well, what's the difference?
CB2 receptors are found primarily in the immune system.
So activating those receptors can help downregulate inflammation without having the psychoactive
effects that we see more with CB1 activation.
Now, remember, CBD oil, cannabidiol, whether it's taken in a prescription pill, which has
been approved for epilepsy, there is one drug that is straight CBD that's been approved
for epilepsy, but it doesn't, and even CBD oils that people get over the counter do not
contain THC.
Now the over the counter ones may contain a little because there isn't nearly the strenuous
regulation on testing and purity and all that stuff.
So if you want to learn more about CBD itself, I have other presentations on the YouTube
channel you can watch, but you know, suffice it to say, because people start hearing cannabinoids
and cannabidiol, and they think cannabis, and then they think THC, and then they think,
oh, that's bad stuff.
Okay.
CBD actually doesn't have psychoactive effects.
It actually doesn't even target directly, still doing it with my hands.
It actually doesn't directly turn on the cannabinoid receptors.
It prevents the degradation of anandamide.
CBD attenuates brain damage associated with neurodegenerative or ischemic conditions.
Because it is neuroprotective, it actually, when the brain upregulates and starts releasing
the glutamate and the cortisol and all that stuff, CBD goes in there and shields, again,
huge oversimplification, but you know, enough for this class.
It shields the neurons.
It helps protect them, coat them from the excitatory neurochemicals.
So think of it like a fire blanket in the middle of a forest fire.
CBD has positive effects of attenuating psychotic, anxiety, and depressive-like behaviors.
Scientists are still learning about the cannabinoid system, the endocannabinoid system.
We don't totally understand how it's involved, but they've started recognizing that the endocannabinoid
system is intertwined with the serotonergic and dopaminergic systems, with the HPA axis,
with the HPG axis.
It's got its little fingers in with everybody, and it has a regulatory effect.
It helps with the self-regulation of some of those systems, and it has been found to
have positive effects on a variety of psychiatric conditions.
They're not sure if by virtue of, for example, preventing the degradation of anandamide,
that creates an effect that increases serotonin and dopamine, or whether just the increase
in things like anandamide actually have positive psychiatric effects.
But they do know CBD tends to have positive effects.
CBD also affects synaptic plasticity and facilitates neurogenesis.
So when people are administered CBD, and when animals are administered CBD, the connections
in their brains tend to be more flexible.
So after a stroke, for example, we want people's brains to have more synaptic plasticity so
it can figure out a workaround around any of the areas of the brain that are permanently
damaged.
But it also facilitates neurogenesis.
It increases the redevelopment of neurons.
It increases generation of new neurons.
That's always, well, probably always a good thing.
So it does have benefits.
CBD indirectly acts as an endogenous cannabinoid receptor agonist.
So just like I said earlier, it indirectly targets and activates the cannabinoid receptors
by making the endogenous cannabinoids more available.
Welcome to the AllCEU's education channel, where you will find long form counselor education
training videos, as well as shorter overview videos geared toward the general public.
We have over 900 videos.
So using the search function that is underneath the subscribe button on our homepage can help
you find the videos that you really want to watch.
You can also find an alphabetized set of some of my most popular playlists at allceus.com
slash YouTube dash playlists.
I absolutely love hearing from you.
So keep those comments coming.
We actually do read all of them and try to respond within a few days.
Have a fabulous day and don't forget to click subscribe and the bell if you haven't already
so you can be notified when I release new videos.
CBD also prevents certain effects caused by the beta amyloid plaques in Alzheimer's disease.
The article did not really talk in depth about how this might be happening, but they do seem
to see some benefit, cognitive benefit in people with Alzheimer's disease who are given
CBD.
Excuse me.
A note about CBD, and I was going to avoid the soapbox, but hey, whatever, CBD that is
sold over the counter, not by prescription, is not highly regulated by the Food and Drug
Administration.
Now, it's not supposed to have more than a certain amount of THC, and I want to say 3%,
but you don't know from bottle to bottle, even from the same manufacturer, the proportion
or the amount of CBD you're getting in each serving.
So it's important to recognize that because of the sort of loosey-goosey standards, that
there can be a lot of variability in what people are getting, even from the same manufacturer.
And that's important to recognize.
CBD also interacts with or causes interactions with most medications.
So if your patients are on any other medication and they say, oh yeah, I heard about this
great stuff, CBD, I'm starting to take it.
It's really advisable to strongly encourage them to make sure their doctor is aware because
their other medications may need to be adjusted.
In vivo evidence for the therapeutic properties of CBD for Alzheimer's disease.
Studies demonstrate the ability of CBD to reduce neuroinflammation and promote neurogenesis
through activation of those CB2 receptors, those receptors that are mainly in your immune
system.
So that's obviously very interesting.
And since it can reduce neuroinflammation, I would wonder, can it also reduce inflammation
inflammation?
Therefore, how effective is it in autoimmune disorders?
And there's a lot of anecdotal evidence that cannabidiol or CBD oil is helpful for inflammation,
for pain, for arthritis, and for those sorts of things.
The research in PubMed is relatively scant right now on straight up CBD.
A lot of the research has either been done on cannabis, which obviously has THC in it,
or on what they call nabixomals, which is a combination of a one-to-one ratio of CBD
and THC.
And the reason they do this is because CBD counteracts a lot of the psychoactive properties
of THC.
But together, they seem to have some very unique, and they call it the entourage effect
because the effect of CBD and the beneficial effects of CBT are not only there, but they're
actually enhance each other, mutually intensify each other when they're presented together,
which is why a lot of studies are using nabixomals.
However, for people who have a history of addiction, for people who are worried about
it, don't want to take anything that has the risk of a psychoactive component, CBD hopefully
will become much more readily available in a standardized fashion.
Anyhow, so a lot of the research you look at is using the nabixomals or the cannabis,
and we can't draw conclusions about what had the effect, whether it was the CBD or the
THC.
Combination therapies of CBD and THC show that CBD can antagonize the psychoactive effects
associated with THC and mediate greater therapeutic effects.
Okay.
This was another interesting thing I learned preparing this class.
CBD acts on more than 65 key targets in the body.
So, wow, that is a lot, including the serotonin 1A receptor, which is the one we typically
think of when we think about depression, and the cannabinoid-related receptors, adenosine
receptors, and mu- and deltoid-opioid receptors.
Wow.
Okay.
So let's just go through those.
Serotonin.
We just finished talking about how serotonin is involved in, or problems in the serotonergic
system are involved in neurodegenerative disorders as well as mood disorders.
Serotonin is involved in pain perception, mood, circadian rhythms, just about every
bodily function.
But not necessarily serotonin 1A.
So it's interesting that CBD specifically acts on serotonin 1A.
The cannabinoid-related receptors we know are involved to a certain extent in helping
regulate the self-feedback mechanisms of a lot of different systems, and it's also involved
in anti-inflammation.
Now, your mu- and delta-opioid receptors are the receptors that are generally targeted
by your endogenous opioids, your internal painkillers, your natural painkillers.
But CBD can actually potentially help activate them.
Now, it's not activating them and giving people a high, but it can help with pain,
help the body modulate its own pain.
CBD has anti-inflammatory, antioxidant, and as a result, antidepressant, antipsychotic,
and anxiolytic properties.
It sounds like a miracle drug.
It's a matter of figuring out, is it as good as we think it is, and how do we get it standardized
so people can get a reasonable dose, and how can we make sure that it's safe since it does
interact with everything?
Not everything, but most drugs.
A large retrospective study with patients with anxiety and poor sleep suggested that
the administration of CBD decreased anxiety rapidly and in a sustained manner and improved
sleep.
So instead of something like your typical benzos that may rapidly reduce anxiety, but
then it rapidly goes back up again, it seems that CBD decreases it and sort of holds it
down as the person dozes off to sleep and maybe even while they're sleeping.
So their sleep quality was improved.
Now, I would be curious about the impact of CBD on the different phases of sleep.
How does it affect REM sleep versus deep sleep?
CBD may also reduce depressive symptoms by stimulating hippocampal neurogenesis.
This is fabulous.
Hippocampal reduction is one of the things that we see as a result of ACEs and trauma.
And the hippocampal reduction is one of the things that we see as a result of ACEs and
trauma.
And the hippocampus is one of those parts of your brain that is involved in emotion
processing.
So if CBD is able to stimulate the regeneration of neurons in the hippocampus, that means
we might be able to build back up this area of the brain that got damaged or gets damaged
from psychological trauma.
Oral CBD, in addition to routine psychiatric care, was associated with PTSD symptom reduction
in adults.
CBD also appeared to offer relief from frequent nightmares as a symptom of PTSD.